SARS-CoV-2 infection in pregnant women assisted in a high-risk maternity hospital in Brazil: Clinical aspects and obstetric outcomes
Open Access
- 11 March 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (3) , e0264901
Abstract
Background: The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the possible development of serious illness, and the possibility of severe obstetric outcomes highlight the importance of addressing SARS-CoV-2 infection in obstetric management. Methods and findings: A cross-sectional study of pregnant women assisted in a high-risk maternity hospital in Brazil in 2020. All patients admitted for delivery or miscarriage care were tested for SARS-CoV-2 using polymerase chain reaction (PCR) and for immunoglobulin (I)gM, and/or IgG by immunochromatography. Clinical aspects and obstetric outcomes were analyzed. A total of 265 pregnant women were included in the study. There were 38 (14.4%) PCR positive cases during pregnancy, 12 (31.6%) on admission screening, and 71(27.2%) patients were IgM- and/or IgG-positive. Among the participants, 86 (32.4%) had at least one positive test during pregnancy. SARS-CoV-2 positive patients had greater contact with known positive patients (p = 0.005). The most frequently reported symptoms were runny nose, cough, loss of smell and taste, headache, and fever. There was also a 35% rate of asymptomatic infections and a 4.6% rate of severe or critical infections. Patients exposed or infected with SARS-CoV-2 had a higher incidence of preterm delivery, cesarean section, need for resuscitation in the delivery room, Apgar score <7 at 5 min, admission to the neonatal intensive care unit, and jaundice. Newborns with at least one positive test had a significantly greater need for phototherapy after delivery (p = 0.05). The results showed a high rate of positive tests among newborns (37.5%), which seems to be compatible with both neonatal and perinatal infection. Conclusions: It is important to further investigate SARS-CoV-2 infection during pregnancy, including the clinical course and the possibility of adverse outcomes with impact on maternal and fetal health, regardless of the development of symptoms.Keywords
Funding Information
- Ministério da Educação (R$: 19.000,00)
This publication has 17 references indexed in Scilit:
- Adverse Pregnancy Outcomes Among Individuals With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Obstetrics & Gynecology, 2021
- Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Network Open, 2020
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ, 2020
- Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological resultsClinical Microbiology and Infection, 2020
- Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care OrganizationAmerican Journal of Perinatology, 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020
- Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19New England Journal of Medicine, 2020
- Universal Screening for SARS-CoV-2 in Women Admitted for DeliveryNew England Journal of Medicine, 2020
- Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her NewbornJAMA, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020